Beta Bionics, Inc. · NASDAQ:BBNX

Hopman Mark sold 370 Beta Bionics, Inc. shares (Form 4)

Traded Nov 2, 2026 · Filed Nov 4, 2026

On Nov 2, 2026, Hopman Mark (Chief Commercial Officer) sold 370 Beta Bionics, Inc. shares at US$16.90 for US$6,253 under a trading plan, leaving 54,143 shares. Filed Nov 4, 2026 (Form 4).

Sold
370 shares
Price
US$16.90
Value
US$6,253
Holding after
54,143 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 2, 2026Common StockSale370US$16.9054,143Direct

Source

Download original · View original at SEC

Related